Castle Biosciences

(NASDAQ) CSTL

Current Price$24.61

Market Cap$734.38M

Since IPO (2019)+13%

5 Year-65%

1 Year+22%

1 Month+3%

Castle Biosciences Financials at a Glance

Market Cap

$734.38M

Revenue (TTM)

$344.23M

Net Income (TTM)

$24.16M

EPS (TTM)

$-0.85

P/E Ratio

-28.62

Dividend

$0.00

Beta (Volatility)

1.47 (Average)

Dividend

$0.00

Beta (Volatility)

1.47 (Average)

Price

$24.61

Volume

13,523

Open

$24.50

Price

$24.61

Volume

13,523

Open

$24.50

Previous Close

$24.24

Daily Range

$24.17 - $24.91

52-Week Range

$14.59 - $44.28

Dividend

$0.00

Beta (Volatility)

1.47 (Average)

Price

$24.61

Volume

13,523

Open

$24.50

Previous Close

$24.24

Daily Range

$24.17 - $24.91

52-Week Range

$14.59 - $44.28

CSTL News

CSTL: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Castle Biosciences

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

883

CEO

Derek J. Maetzold

Website

www.castlebiosciences.com

Headquarters

Friendswood, TX 77546, US

CSTL Financials

Key Financial Metrics (TTM)

Gross Margin

69%

Operating Margin

-12%

Net Income Margin

-7%

Return on Equity

-5%

Return on Capital

-8%

Return on Assets

-4%

Earnings Yield

-3.49%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$734.38M

Shares Outstanding

30.30M

Volume

13.52K

Avg. Volume

375.89K

Financials (TTM)

Gross Profit

$236.35M

Operating Income

$42.81M

EBITDA

$11.34M

Operating Cash Flow

$64.35M

Capital Expenditure

$36.02M

Free Cash Flow

$28.33M

Cash & ST Invst.

$299.50M

Total Debt

$36.91M

Castle Biosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$87.01M

+0.8%

Gross Profit

$31.84M

-54.6%

Gross Margin

36.59%

N/A

Market Cap

$734.38M

N/A

Market Cap/Employee

$936.70K

N/A

Employees

784

N/A

Net Income

$2.33M

-124.3%

EBITDA

$1.09M

-92.1%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$262.59M

-1.6%

Accounts Receivable

$43.38M

-15.3%

Inventory

$10.25M

+26.0%

Long Term Debt

$35.17M

+44.1%

Short Term Debt

$1.74M

-10.3%

Return on Assets

-4.18%

N/A

Return on Invested Capital

-8.40%

N/A

Free Cash Flow

$19.75M

+17.6%

Operating Cash Flow

$26.93M

+10.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

AMNAMN Healthcare Services, Inc.

AMNAMN Healthcare Services, Inc.$20.59-2.69%

EMBCEmbecta Corp.

EMBCEmbecta Corp.$8.89+2.07%

GERNGeron Corporation

GERNGeron Corporation$1.52+0.85%

PSNLPersonalis, Inc.

PSNLPersonalis, Inc.$5.16+2.37%

FLGTFulgent Genetics, Inc.

FLGTFulgent Genetics, Inc.$15.09+1.94%

MYGNMyriad Genetics, Inc.

MYGNMyriad Genetics, Inc.$4.77+1.93%

EVHEvolent Health, Inc.

EVHEvolent Health, Inc.$3.71-1.98%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$12.26-0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$62.08+0.00%

MARAMara Holdings

MARAMara Holdings$11.78+0.10%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.52+0.07%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.01+0.01%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$52.98-0.00%

HTZHertz Global

HTZHertz Global$6.67+0.19%

Questions About CSTL

What is the current price of Castle Biosciences?

Castle Biosciences is trading at $24.61 per share.

What is the 52-week range for Castle Biosciences?

Over the past 52 weeks, Castle Biosciences has traded between $14.59 and $44.28.

How much debt does Castle Biosciences have?

As of the most recent reporting period, Castle Biosciences reported total debt of $37.02M.

How much cash does Castle Biosciences have on hand?

Castle Biosciences reported $116.73M in cash and cash equivalents in its most recent financial results.

What is Castle Biosciences’s dividend yield?

Castle Biosciences does not currently have a dividend yield.

Castle Biosciences

Castle Biosciences Financials at a Glance

CSTL News

Castle (CSTL) Q2 Revenue Tops Estimates

Why Castle Biosciences Stock Is Jumping Today

Why Shares of Castle Biosciences Fell This Week

Why Castle Biosciences Stock Is Crushing It Today

Why Shares of Castle Biosciences Plummeted on Monday

Why Shares of Castle Biosciences Slumped This Week

CSTL: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Castle Biosciences

CSTL Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Castle Biosciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CSTL

What is the current price of Castle Biosciences?

What is the 52-week range for Castle Biosciences?

How much debt does Castle Biosciences have?

How much cash does Castle Biosciences have on hand?

What is Castle Biosciences’s dividend yield?

Premium Investing Services